Occurrence of new-onset atrial fibrillation (AF) in the month following acute myocardial infarction (AMI) was…
-
-
Research & Treatment
Transient Resumption of Cardiac Activity After Life-Sustaining Measure Withdrawal
Transient resumption of at least 1 cycle of cardiac activity after pulselessness was observed in…
-
Hypertension
Increased NT-ProBNP May Help Identify Patients at High Risk for CVD Across BP Categories
Elevated levels of N-terminal pro–B-type natriuretic peptide (NT-proBNP) may represent a useful biomarker for the…
-
Abnormalities prominent in heart failure with reduced ejection fraction (HFrEF), including disruption of cardiomyocyte t-tubules…
-
Ethnic disparities persist for treatment and clinical outcomes among patients with heart failure (HF) in…
-
Research & Treatment
Treatment of Patients With HFrEF With Empagliflozin Associated With Improved Systolic Function and LV Volume, Mass
Treatment of nondiabetic patients with heart failure with reduced ejection fraction (HFrEF) with empagliflozin was…
-
Hypertension
Blood Pressure Variability May Be Associated With CV Events, Mortality in Patients With Nondialysis Chronic Kidney Disease
Blood pressure variability (BPV) may be associated with cardiovascular events and death but not end-stage…
-
Patients with heart failure with reduced ejection fraction (HFrEF) who were diabetic or prediabetic had…
-
Peak atrial longitudinal strain (PALS) and peak atrial contraction strain (PACS) were found to improve…
-
Treatment of patients with heart failure with preserved ejection fraction (HFpEF) with sodium nitrite was…